Characterization of pseudotype VSV possessing HCV envelope proteins
- PMID: 11485395
- DOI: 10.1006/viro.2001.0971
Characterization of pseudotype VSV possessing HCV envelope proteins
Abstract
The genome of hepatitis C virus (HCV) encodes two envelope glycoproteins (E1 and E2), which are thought to be responsible for receptor binding and membrane fusion resulting in virus penetration. To investigate cell surface determinants important for HCV infection, we used a recombinant vesicular stomatitis virus (VSV) in which the glycoprotein gene was replaced with a reporter gene encoding green fluorescent protein (GFP) and produced HCV-VSV pseudotypes possessing chimeric HCV E1 or E2 glycoproteins, either individually or together. The infectivity of the pseudotypes was determined by quantifying the number of cells expressing the GFP reporter gene. Pseudotypes that contained both of the chimeric E1 and E2 proteins exhibited 10--20 times higher infectivity on HepG2 cells than the viruses possessing either of the glycoproteins individually. These results indicated that both E1 and E2 envelope proteins are required for maximal infection by HCV. The infectivity of the pseudotype virus was not neutralized by anti-VSV polyclonal antibodies. Bovine lactoferrin specifically inhibited the infection of the pseudotype virus. Treatment of HepG2 cells with Pronase, heparinase, and heparitinase but not with phospholipase C and sodium periodate reduced the infectivity. Therefore, cell surface proteins and some glycosaminoglycans play an important role in binding or entry of HCV into susceptible cells. The pseudotype VSV possessing the chimeric HCV glycoproteins might offer an efficient tool for future research on cellular receptors for HCV and for the development of prophylactics and therapeutics for hepatitis C.
Copyright 2001 Academic Press.
Similar articles
-
Efficient formation of vesicular stomatitis virus pseudotypes bearing the native forms of hepatitis C virus envelope proteins detected after sonication.Microbes Infect. 2005 Jan;7(1):29-40. doi: 10.1016/j.micinf.2004.09.006. Epub 2004 Dec 9. Microbes Infect. 2005. PMID: 15716060
-
Functional features of hepatitis C virus glycoproteins for pseudotype virus entry into mammalian cells.Virology. 2000 Oct 10;276(1):214-26. doi: 10.1006/viro.2000.0547. Virology. 2000. PMID: 11022009
-
Influence of N-linked glycans on intracellular transport of hepatitis C virus E1 chimeric glycoprotein and its role in pseudotype virus infectivity.Virology. 2004 Jul 1;324(2):273-85. doi: 10.1016/j.virol.2004.03.039. Virology. 2004. PMID: 15207615
-
Hepatitis C virus entry: an intriguing challenge for drug discovery.Curr Opin Investig Drugs. 2006 Aug;7(8):727-32. Curr Opin Investig Drugs. 2006. PMID: 16955684 Review.
-
[Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins].Ann Biol Clin (Paris). 2007 May-Jun;65(3):237-46. Ann Biol Clin (Paris). 2007. PMID: 17502294 Review. French.
Cited by
-
Modified DNA vaccine confers improved humoral immune response and effective virus protection against SARS-CoV-2 delta variant.Sci Rep. 2022 Dec 3;12(1):20923. doi: 10.1038/s41598-022-24519-5. Sci Rep. 2022. PMID: 36463322 Free PMC article.
-
The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus.EMBO J. 2002 Oct 1;21(19):5017-25. doi: 10.1093/emboj/cdf529. EMBO J. 2002. PMID: 12356718 Free PMC article.
-
Diverging effects of human recombinant anti-hepatitis C virus (HCV) antibody fragments derived from a single patient on the infectivity of a vesicular stomatitis virus/HCV pseudotype.J Virol. 2002 Nov;76(22):11775-9. doi: 10.1128/jvi.76.22.11775-11779.2002. J Virol. 2002. PMID: 12388741 Free PMC article.
-
Safety and immunogenicity of SARS-CoV-2 self-amplifying RNA vaccine expressing an anchored RBD: A randomized, observer-blind phase 1 study.Cell Rep Med. 2023 Aug 15;4(8):101134. doi: 10.1016/j.xcrm.2023.101134. Cell Rep Med. 2023. PMID: 37586325 Free PMC article. Clinical Trial.
-
Crystal structure of Mokola virus glycoprotein in its post-fusion conformation.PLoS Pathog. 2020 Mar 9;16(3):e1008383. doi: 10.1371/journal.ppat.1008383. eCollection 2020 Mar. PLoS Pathog. 2020. PMID: 32150590 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources